Reaction-First Evolutionary Metaheuristic Algorithm

• The topic is a population-based optimization method that enforces chemically valid recombination operations before other mutations to improve exploration and solution feasibility.
• It employs adaptive collision rates and multi-objective fitness metrics to balance global search dynamics with structural and constraint-driven requirements.
• Applications include continuous global optimization and personalized drug design, where reaction-first ordering ensures synthetic plausibility and spatial accuracy.

A reaction-first evolutionary metaheuristic algorithm is a class of population-based optimization technique in which chemically inspired transformation operators are applied to candidate solutions in a prescribed reaction-first order, with special attention given to the molecular assembly or recombination step before other mutation or crossover operations. This approach is prominent in both continuous global optimization—where it is exemplified by the Reaction-First Chemical Reaction Optimization with Adaptive Collisions (CRO/AC) (Yu et al., 2015)—and in molecular design, notably for personalized drug generation via fragment-based assembly guided by multi-objective fitness (Elafifi et al., 24 Dec 2025). These algorithms leverage a chemical analogy to both control exploration/exploitation dynamics and facilitate physically or synthetically plausible solutions in high-dimensional or highly constrained domains.

1. Foundational Principles and Reaction-First Workflow

The reaction-first evolutionary metaheuristic is characterized by enforcing chemically valid recombination operations—such as SMARTS-based reaction merges—prior to other manipulations (e.g., random crossover, graph recombination). In the CRO/AC algorithm (Yu et al., 2015), each iteration is conceptualized as an elementary reaction in a closed reactor containing a population $P$ of molecules, each with structure $\omega \in \mathbb{R}^D$, potential energy $\mathrm{PE}=f(\omega)$, kinetic energy $\mathrm{KE}$, and a global energy buffer $\mathrm{EB}$. Molecular transformations are triggered based on a sampled rate parameter $u$ compared to an adaptive collision rate $\mathit{collRate}$:

• If $u < \mathit{collRate}$, an inter-molecular collision (Inter) or synthesis (Syn) occurs;
• Otherwise, an on-wall (Onwall) or decomposition (Dec) takes place.

In chemical assembly for de novo drug design (Elafifi et al., 24 Dec 2025), the evolutionary loop begins by assembling candidate ligands from curated fragment libraries, attempting reaction-first merges (chemical reactions) aligned to protein hotspots before any fallback assembly via graph operations.

This workflow prioritizes chemical feasibility and spatial relevance (in structure-based design) and ensures energy-conserving operations in optimization, with population and operator selection governed adaptively.

2. Operator Design and Mathematical Formalism

Chemical Reaction Optimization (CRO/AC)

The key operators in CRO/AC are defined formally as follows:

• Neighborhood Search: For continuous perturbation in Onwall/Dec/Syn, $\omega'_i = \omega_i + \epsilon$ where $\epsilon \sim \mathcal{N}(0,\mathit{stepSize})$.
• Inter-Molecular Collision (Inter): Applied to two molecules $\omega_s,\omega_t$ where $\mathrm{PE}(\omega_s) \geq \mathrm{PE}(\omega_t)$. An independent two-step procedure per dimension $i$:
  • Step 1: $$\omega'_{s,i} = \omega_{s,i} + r_i (\omega_{t,i} - \omega_{s,i}),\; r_i \sim \mathrm{Uniform}[0,1)$$
  • Step 2: $$\omega'_{t,i} = \omega_{t,i} + r'_i (\omega_{t,i} - \omega'_{s,i}),\; r'_i \sim \mathrm{Uniform}[0,1)$$

Fragment Assembly in Drug Design

• Alignment: Each fragment is oriented toward a pre-identified pocket hotspot $h$ using the Rodrigues rotation matrix $R = I + \sin\theta K + (1-\cos\theta)K^2$, where $K$ is skew-symmetric based on principal axes.
• Chemical Merges: A reaction-first SMARTS-based merge is attempted, falling back to BRICS safe merge only if reaction templates fail. Chemical sanitization follows.
• Multi-objective Fitness: Composite ligand score $F(m)$ is calculated as:

$$F(m) = w_p S_\mathrm{proxy} + w_f S_\mathrm{fit} + w_n S_\mathrm{novelty} + w_s S_\mathrm{strain} - \lambda P_\mathrm{SA}$$

with $S_\mathrm{fit}$ defined as:

$$S_\mathrm{fit} = 0.6 F_\mathrm{inside} + 0.4 \left(1 - \frac{\bar d_\mathrm{hot}}{\bar d_\mathrm{hot} + 4.0}\right)$$

3. Adaptive Strategies and Constraint Mechanisms

In CRO/AC, the collision rate is not fixed. Instead, it is dynamically adjusted according to the running difference between the count of successful inter-molecular collisions and successful on-wall collisions:

$$\mathit{collRate} = \frac{1}{1 + \exp\left(-6\,\frac{\mathtt{counter}}{\mathrm{maxFE}}\right)}$$

where $$\mathtt{counter} = \#(\text{successful Inters}) - \#(\text{successful Onwalls})$$ and $\mathrm{maxFE}$ is the function evaluation budget (Yu et al., 2015).

For chemical assembly, constraint satisfaction is enforced by:

• Failing merges if chemical valence, connectivity, or aromaticity is violated;
• Penalizing synthetic inaccessibility in fitness by $P_\mathrm{SA}$;
• Using cluster analysis (k-means) to focus spatial alignment for pocket hotspots.

No additional hyper-adaptive tuning beyond empirical parameter selection for weights and penalties is described in the drug assembly domain (Elafifi et al., 24 Dec 2025).

4. Integration with Structural and Objective Information

The reaction-first metaheuristic assembly leverages structural information from molecular targets (e.g., protein pockets) and incorporates it into candidate generation and selection. In drug design, pockets are scored (DOGSiteScorer) by

$$\mathrm{Score} = 0.3\,\mathrm{Vol} + 0.2\,\mathrm{Depth} + 0.2\,(100 \cdot \mathrm{Enclosure}) + 0.1\,(100 \cdot \mathrm{Hydrophobicity}) + 0.1\,\mathrm{Aromaticity} + 0.1\,(D+A)$$

and the spatial fitness $S_\mathrm{fit}$ directly evaluates the geometric relationship of candidate ligands to the identified hotspots.

In continuous optimization (CRO/AC), the energy conservation principle (sum of $\mathrm{PE}$, $\mathrm{KE}$, $\mathrm{EB}$) constrains progression, reinforcing physical plausibility in exploration.

5. Pseudocode Structure and Computational Cost

Representative pseudocode structures for reaction-first metaheuristics adhere to the following paradigm:

CRO/AC (Yu et al., 2015)

Initialize population P, set KE, EB, counter = 0 while FE < maxFE: collRate = 1/(1 + exp(-6 * counter / maxFE)) u = Uniform[0,1) if u < collRate: if |P| > 2 and rand() < 0.5: Inter collision (two-step update) else: Syn (random merger) else: v = Uniform[0,1) if v < 0.5 or |P|==1: Onwall else: Dec (split) Apply energy check: if PE+KE+EB not increased, commit; else revert FE += number of function evaluations return best ω

Metaheuristic Ligand Generation (Elafifi et al., 24 Dec 2025)

For each generation g in 1..G: For each of K candidates: Select f1, f2 from fragment library Choose hotspot h Align fragments to h (Rodrigues) Attempt reaction merge, else safe BRICS merge If valid and sanitized, compute properties and scores Assign composite fitness F Select K survivors by F Return aggregate survivors

Each reaction in CRO/AC requires $O(D)$ cost per iteration, with the overall complexity bounded by $O(\mathrm{maxFE} \times D)$. The overhead for operator adaptation and multi-dimensional collision is marginal ($O(D)$). For drug assembly, cost is dominated by fragment alignment, reaction checks, and fitness evaluation, with $G \times K$ merges and scoring steps per run.

6. Benchmark Performance and Convergence Profiles

In the CRO/AC study (Yu et al., 2015), 16 benchmark functions (rotated/shifted/penalized, dimensionality $D=30$) were optimized under a $300{,}000$ FE budget. CRO/AC achieved the best mean solution value on 14/16 functions and statistical superiority over canonical RCCRO variants in nearly all cases, especially on rotated functions (e.g., Rotated Rastrigin $f_{10}$: mean $\approx 143.8$, canonical $\approx 435.7$; Rotated Schwefel $f_8$: global optimum in all runs).

For personalized drug assembly (Elafifi et al., 24 Dec 2025), generational fitness convergence is observed by generation 15–20, with proxy scores (drug-likeness) peaking at $\approx 0.7$ and novelty near 1.0. QED (Quantitative Estimate of Drug-likeness) scores dominate in the $0.5$–$0.7$ range, and PocketFit scores stabilize around $0.710$. Binding energies for top candidates are measured at $\Delta G = -6.571$ kcal/mol and $-6.800$ kcal/mol depending on the docking engine.

7. Contexts of Optimal Performance and Limitations

CRO/AC excels in problems with strong inter-dimensional correlations and multimodal landscapes. The two-step Inter operator enables multi-dimensional search and mitigates premature convergence, while the adaptive collision rate strategically shifts operator usage as search proceeds (Yu et al., 2015).

For reaction-first metaheuristic drug assembly, the approach is particularly suited for situations demanding synthetic plausibility and spatial hotspot alignment, demonstrated in personalized AML therapeutic candidate generation (Elafifi et al., 24 Dec 2025). The enforced workflow increases the physical and chemical relevance of solutions.

A plausible implication is that reaction-first ordering yields benefits in domains where primary assembly events constrain downstream diversity or objective properties. In both continuous and combinatorial domains, the operator design and adaptive schedule are directly linked to search efficiency and solution quality.

---

References:

Lam et al., "An Inter-molecular Adaptive Collision Scheme for Chemical Reaction Optimization" (Yu et al., 2015); "Transcriptome-Conditioned Personalized De Novo Drug Generation for AML Using Metaheuristic Assembly and Target-Driven Filtering" (Elafifi et al., 24 Dec 2025).